Kumagai, Y., Fujita, T., Maeda, M., Yamamoto, A., & Amano, H. (2025). Pharmacology and safety of TAS5315, a Bruton tyrosine kinase inhibitor, in healthy volunteers: First‐in‐human, randomized, ascending‐dose studies. Wiley. https://doi.org/10.1002/bcp.70039
Chicago-Zitierstil (17. Ausg.)Kumagai, Yuji, Tomoe Fujita, Mika Maeda, Akiko Yamamoto, und Hideki Amano. Pharmacology and Safety of TAS5315, a Bruton Tyrosine Kinase Inhibitor, in Healthy Volunteers: First‐in‐human, Randomized, Ascending‐dose Studies. Wiley, 2025. https://doi.org/10.1002/bcp.70039.
MLA-Zitierstil (9. Ausg.)Kumagai, Yuji, et al. Pharmacology and Safety of TAS5315, a Bruton Tyrosine Kinase Inhibitor, in Healthy Volunteers: First‐in‐human, Randomized, Ascending‐dose Studies. Wiley, 2025. https://doi.org/10.1002/bcp.70039.